Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136

1.

Correction: Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation.

Yan Y, Hein AL, Etekpo A, Burchett KM, Lin C, Enke CA, Batra SK, Cowan KH, Ouellette MM.

Oncotarget. 2020 Jan 21;11(3):304. doi: 10.18632/oncotarget.27450. eCollection 2020 Jan 21.

2.

PR55α regulatory subunit of PP2A inhibits the MOB1/LATS cascade and activates YAP in pancreatic cancer cells.

Hein AL, Brandquist ND, Ouellette CY, Seshacharyulu P, Enke CA, Ouellette MM, Batra SK, Yan Y.

Oncogenesis. 2019 Oct 28;8(11):63. doi: 10.1038/s41389-019-0172-9.

3.

Technical Assessment of an Automated Treatment Planning on Dose Escalation of Pancreas Stereotactic Body Radiotherapy.

Wang S, Zheng D, Lin C, Lei Y, Verma V, Smith A, Ma R, Enke CA, Zhou S.

Technol Cancer Res Treat. 2019 Jan 1;18:1533033819851520. doi: 10.1177/1533033819851520.

4.

Can the Student Outperform the Master? A Plan Comparison Between Pinnacle Auto-Planning and Eclipse knowledge-Based RapidPlan Following a Prostate-Bed Plan Competition.

Smith A, Granatowicz A, Stoltenberg C, Wang S, Liang X, Enke CA, Wahl AO, Zhou S, Zheng D.

Technol Cancer Res Treat. 2019 Jan-Dec;18:1533033819851763. doi: 10.1177/1533033819851763.

5.

Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

Mohler JL, Antonarakis ES, Armstrong AJ, D'Amico AV, Davis BJ, Dorff T, Eastham JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, Hurwitz M, Ippolito JE, Kane CJ, Kuettel MR, Lang JM, McKenney J, Netto G, Penson DF, Plimack ER, Pow-Sang JM, Pugh TJ, Richey S, Roach M, Rosenfeld S, Schaeffer E, Shabsigh A, Small EJ, Spratt DE, Srinivas S, Tward J, Shead DA, Freedman-Cass DA.

J Natl Compr Canc Netw. 2019 May 1;17(5):479-505. doi: 10.6004/jnccn.2019.0023.

PMID:
31085757
6.

Times Not to Forget Radiotherapy When Treating Patients With Lymphoma.

Enke CA.

J Oncol Pract. 2019 Apr;15(4):167-172. doi: 10.1200/JOP.18.00519.

PMID:
30970228
7.

Availability and Use of Workplace Supports for Health Promotion Among Employees of Small and Large Businesses.

Dale AM, Enke C, Buckner-Petty S, Hipp JA, Marx C, Strickland J, Evanoff B.

Am J Health Promot. 2019 Jan;33(1):30-38. doi: 10.1177/0890117118772510. Epub 2018 Apr 26.

8.

Exploring the differential impact of individual and organizational factors on organizational commitment of physicians and nurses.

Miedaner F, Kuntz L, Enke C, Roth B, Nitzsche A.

BMC Health Serv Res. 2018 Mar 15;18(1):180. doi: 10.1186/s12913-018-2977-1.

9.

Rac1 is a novel therapeutic target in mantle cell lymphoma.

Tian T, Bi C, Hein AL, Zhang X, Wang C, Shen S, Yuan J, Greiner TC, Enke C, Vose J, Yan Y, Fu K.

Blood Cancer J. 2018 Feb 12;8(2):17. doi: 10.1038/s41408-018-0052-0. No abstract available.

10.

Volume, size, professionals' specialization and nutrition management of NICUs and their association with treatment quality in VLBW infants.

Miedaner F, Langhammer K, Enke C, Göpel W, Kribs A, Nitzsche A, Riedel R, Woopen C, Kuntz L, Roth B.

J Perinatol. 2018 Apr;38(4):402-410. doi: 10.1038/s41372-017-0036-0. Epub 2018 Jan 25.

PMID:
29371627
11.

Using weighted power mean for equivalent square estimation.

Zhou S, Wu Q, Li X, Ma R, Zheng D, Wang S, Zhang M, Li S, Lei Y, Fan Q, Hyun M, Diener T, Enke C.

J Appl Clin Med Phys. 2017 Nov;18(6):194-199. doi: 10.1002/acm2.12201. Epub 2017 Oct 31.

12.

Automatic planning on hippocampal avoidance whole-brain radiotherapy.

Wang S, Zheng D, Zhang C, Ma R, Bennion NR, Lei Y, Zhu X, Enke CA, Zhou S.

Med Dosim. 2017 Spring;42(1):63-68. doi: 10.1016/j.meddos.2016.12.002.

PMID:
28237294
13.

Comparing organ-at-risk doses for high-dose-rate vaginal brachytherapy between three different planning workflows.

Gruhl JD, Zheng D, Longo JL, Enke C, Wahl AO.

Brachytherapy. 2017 Mar - Apr;16(2):373-377. doi: 10.1016/j.brachy.2016.11.008. Epub 2016 Dec 28.

PMID:
28039010
14.

Communicating with parents in neonatal intensive care units: The impact on parental stress.

Enke C, Oliva Y Hausmann A, Miedaner F, Roth B, Woopen C.

Patient Educ Couns. 2017 Apr;100(4):710-719. doi: 10.1016/j.pec.2016.11.017. Epub 2016 Nov 22.

PMID:
27923673
15.

Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume?

Verma V, Chen S, Zhou S, Enke CA, Wahl AO.

Strahlenther Onkol. 2017 Jan;193(1):38-45. doi: 10.1007/s00066-016-1077-6. Epub 2016 Dec 1.

PMID:
27909738
16.

Estimation of internal organ motion-induced variance in radiation dose in non-gated radiotherapy.

Zhou S, Zhu X, Zhang M, Zheng D, Lei Y, Li S, Bennion N, Verma V, Zhen W, Enke C.

Phys Med Biol. 2016 Dec 7;61(23):8157-8179. Epub 2016 Nov 2.

PMID:
27804926
17.

Distance-of-Flight Mass Spectrometry: What, Why, and How?

Dennis EA, Gundlach-Graham AW, Ray SJ, Enke CG, Hieftje GM.

J Am Soc Mass Spectrom. 2016 Nov;27(11):1772-1786. Epub 2016 Aug 25.

PMID:
27562501
18.

RAC1 GTPase promotes the survival of breast cancer cells in response to hyper-fractionated radiation treatment.

Hein AL, Post CM, Sheinin YM, Lakshmanan I, Natarajan A, Enke CA, Batra SK, Ouellette MM, Yan Y.

Oncogene. 2016 Dec 8;35(49):6319-6329. doi: 10.1038/onc.2016.163. Epub 2016 May 16.

19.

Prostate Cancer, Version 1.2016.

Mohler JL, Armstrong AJ, Bahnson RR, D'Amico AV, Davis BJ, Eastham JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, Hurwitz M, Kane CJ, Kawachi MH, Kuettel M, Lee RJ, Meeks JJ, Penson DF, Plimack ER, Pow-Sang JM, Raben D, Richey S, Roach M 3rd, Rosenfeld S, Schaeffer E, Skolarus TA, Small EJ, Sonpavde G, Srinivas S, Strope SA, Tward J, Shead DA, Freedman-Cass DA.

J Natl Compr Canc Netw. 2016 Jan;14(1):19-30.

PMID:
26733552
20.

Inductively Coupled Plasma Zoom-Time-of-Flight Mass Spectrometry.

Dennis EA, Ray SJ, Enke CG, Hieftje GM.

J Am Soc Mass Spectrom. 2016 Mar;27(3):380-7. doi: 10.1007/s13361-015-1309-5. Epub 2015 Dec 3.

PMID:
26634932
21.

The Analog Revolution and Its On-Going Role in Modern Analytical Measurements.

Enke CG.

Anal Chem. 2015 Dec 15;87(24):11935-47. doi: 10.1021/acs.analchem.5b02405. Epub 2015 Dec 2.

PMID:
26629976
22.

Distance-of-Flight Mass Spectrometry with IonCCD Detection and an Inductively Coupled Plasma Source.

Dennis EA, Ray SJ, Enke CG, Gundlach-Graham AW, Barinaga CJ, Koppenaal DW, Hieftje GM.

J Am Soc Mass Spectrom. 2016 Mar;27(3):371-9. doi: 10.1007/s13361-015-1295-7. Epub 2015 Nov 9.

PMID:
26552388
23.

Technical Note: Fabricating Cerrobend grids with 3D printing for spatially modulated radiation therapy: A feasibility study.

Zhu X, Driewer J, Li S, Verma V, Lei Y, Zhang M, Zhang Q, Zheng D, Cullip T, Chang SX, Wang AZ, Zhou S, Enke CA.

Med Phys. 2015 Nov;42(11):6269-73. doi: 10.1118/1.4932223.

PMID:
26520719
24.

Effect of response factor variations on the response distribution of complex mixtures.

Gundlach-Graham A, Enke C.

Eur J Mass Spectrom (Chichester). 2015;21(3):471-9. doi: 10.1255/ejms.1369.

PMID:
26307728
25.

Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation.

Yan Y, Hein AL, Etekpo A, Burchett KM, Lin C, Enke CA, Batra SK, Cowan KH, Ouellette MM.

Oncotarget. 2014 Nov 15;5(21):10251-70. Erratum in: Oncotarget. 2020 Jan 21;11(3):304.

26.

Preclinical evaluation of investigational radiopharmaceutical RISAD-P intended for use as a diagnostic and molecular radiotherapy agent for prostate cancer.

Kortylewicz ZP, Mack E, Enke CA, Estes KA, Mosley RL, Baranowska-Kortylewicz J.

Prostate. 2015 Jan;75(1):8-22. doi: 10.1002/pros.22885. Epub 2014 Oct 4.

PMID:
25283970
27.

A new variable for SRS plan quality evaluation based on normal tissue sparing: the effect of prescription isodose levels.

Zhang Q, Zheng D, Lei Y, Morgan B, Driewer J, Zhang M, Li S, Zhou S, Zhen W, Thompson R, Wahl A, Lin C, Enke C.

Br J Radiol. 2014 Nov;87(1043):20140362. doi: 10.1259/bjr.20140362. Epub 2014 Sep 16.

28.

Zoom-TOFMS: addition of a constant-momentum-acceleration "zoom" mode to time-of-flight mass spectrometry.

Dennis EA, Gundlach-Graham AW, Ray SJ, Enke CG, Barinaga CJ, Koppenaal DW, Hieftje GM.

Anal Bioanal Chem. 2014 Nov;406(29):7419-30. doi: 10.1007/s00216-014-7875-8. Epub 2014 May 28.

PMID:
24866712
29.

Prostate cancer, version 2.2014.

Mohler JL, Kantoff PW, Armstrong AJ, Bahnson RR, Cohen M, D'Amico AV, Eastham JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, Kane CJ, Kawachi MH, Kuettel M, Kuzel TM, Lee RJ, Malcolm AW, Miller D, Plimack ER, Pow-Sang JM, Raben D, Richey S, Roach M 3rd, Rohren E, Rosenfeld S, Schaeffer E, Small EJ, Sonpavde G, Srinivas S, Stein C, Strope SA, Tward J, Shead DA, Ho M; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2014 May;12(5):686-718.

PMID:
24812137
30.

Prostate cancer, version 1.2014.

Mohler JL, Kantoff PW, Armstrong AJ, Bahnson RR, Cohen M, D'Amico AV, Eastham JA, Enke CA, Farrington TA, Higano CS, Horwitz EM, Kawachi MH, Kuettel M, Lee RJ, Macvicar GR, Malcolm AW, Miller D, Plimack ER, Pow-Sang JM, Richey S, Roach M 3rd, Rohren E, Rosenfeld S, Small EJ, Srinivas S, Stein C, Strope SA, Tward J, Walsh PC, Shead DA, Ho M; National comprehensive cancer network.

J Natl Compr Canc Netw. 2013 Dec 1;11(12):1471-9.

PMID:
24335682
31.

A nonhuman primate model of human radiation-induced venocclusive liver disease and hepatocyte injury.

Yannam GR, Han B, Setoyama K, Yamamoto T, Ito R, Brooks JM, Guzman-Lepe J, Galambos C, Fong JV, Deutsch M, Quader MA, Yamanouchi K, Kabarriti R, Mehta K, Soto-Gutierrez A, Roy-Chowdhury J, Locker J, Abe M, Enke CA, Baranowska-Kortylewicz J, Solberg TD, Guha C, Fox IJ.

Int J Radiat Oncol Biol Phys. 2014 Feb 1;88(2):404-411. doi: 10.1016/j.ijrobp.2013.10.037. Epub 2013 Dec 5.

32.

Constant-momentum acceleration time-of-flight mass spectrometry with energy focusing.

Dennis EA, Ray SJ, Gundlach-Graham AW, Enke CG, Barinaga CJ, Koppenaal DW, Hieftje GM.

J Am Soc Mass Spectrom. 2013 Dec;24(12):1853-61. doi: 10.1007/s13361-013-0723-9. Epub 2013 Oct 1.

PMID:
24081835
33.

Interleaved Distance-of-Flight Mass Spectrometry: A Simple Method to Improve the Instrument Duty Factor.

Gundlach-Graham A, Dennis EA, Ray SJ, Enke CG, Barinaga CJ, Koppenaal DW, Hieftje GM.

J Am Soc Mass Spectrom. 2013 Nov;24(11):1736-44. doi: 10.1007/s13361-013-0718-6. Epub 2013 Aug 28.

PMID:
23982936
34.

Jim Morrison, Friend and Colleague.

Enke CG, Yost RA.

J Am Soc Mass Spectrom. 2013 Sep;24(9):1319-23. doi: 10.1007/s13361-013-0692-z. Epub 2013 Jul 23.

PMID:
23877476
35.

How constant momentum acceleration decouples energy and space focusing in distance-of-flight and time-of-flight mass spectrometries.

Dennis EA, Gundlach-Graham AW, Enke CG, Ray SJ, Carado AJ, Barinaga CJ, Koppenaal DW, Hieftje GM.

J Am Soc Mass Spectrom. 2013 May;24(5):690-700. doi: 10.1007/s13361-013-0587-z. Epub 2013 Mar 23.

PMID:
23526167
36.

Cellular immunotherapy study of prostate cancer patients and resulting IgG responses to peptide epitopes predicted from prostate tumor-associated autoantigens.

Hemstreet GP 3rd, Rossi GR, Pisarev VM, Enke CA, Helfner L, Hauke RJ, Tennant L, Ramsey WJ, Vahanian NN, Link CJ.

J Immunother. 2013 Jan;36(1):57-65. doi: 10.1097/CJI.0b013e3182780abc.

PMID:
23211622
37.

Extension of the focusable mass range in distance-of-flight mass spectrometry with multiple detectors.

Gundlach-Graham AW, Dennis EA, Ray SJ, Enke CG, Carado AJ, Barinaga CJ, Koppenaal DW, Hieftje GM.

Rapid Commun Mass Spectrom. 2012 Nov 15;26(21):2526-34. doi: 10.1002/rcm.6379.

PMID:
23008070
38.

Prostate cancer, Version 3.2012: featured updates to the NCCN guidelines.

Mohler JL, Armstrong AJ, Bahnson RR, Boston B, Busby JE, D'Amico AV, Eastham JA, Enke CA, Farrington T, Higano CS, Horwitz EM, Kantoff PW, Kawachi MH, Kuettel M, Lee RJ, MacVicar GR, Malcolm AW, Miller D, Plimack ER, Pow-Sang JM, Roach M 3rd, Rohren E, Rosenfeld S, Srinivas S, Strope SA, Tward J, Twardowski P, Walsh PC, Ho M, Shead DA.

J Natl Compr Canc Netw. 2012 Sep;10(9):1081-7.

PMID:
22956807
39.

Phase II trial of 131-Iodine tositumomab with high-dose chemotherapy and autologous stem cell transplantation for relapsed diffuse large B cell lymphoma.

Vose JM, Bierman PJ, Loberiza FR, Enke C, Hankins J, Bociek RG, Chan WC, Weisenburger DD, Armitage JO.

Biol Blood Marrow Transplant. 2013 Jan;19(1):123-8. doi: 10.1016/j.bbmt.2012.08.013. Epub 2012 Aug 29.

40.

SU-E-J-122: Quantification of Respiratory-Induced Pancreatic Head Tumor Rotation and Deformation Using 4DCT and Fiducial Markers.

Chen S, Lin C, Enke C, Zhou S.

Med Phys. 2012 Jun;39(6Part8):3680. doi: 10.1118/1.4734958.

PMID:
28518929
41.

SU-E-T-206: Standardization in Documentation Format Can Significantly Reduce Manual Data Entry Error in Patient Chart.

Zhou S, Chen S, Wahl A, Enke C.

Med Phys. 2012 Jun;39(6Part13):3750. doi: 10.1118/1.4735266.

PMID:
28517317
42.

Distance-of-flight mass spectrometry: a new paradigm for mass separation and detection.

Enke CG, Ray SJ, Graham AW, Dennis EA, Hieftje GM, Carado AJ, Barinaga CJ, Koppenaal DW.

Annu Rev Anal Chem (Palo Alto Calif). 2012;5:487-504. doi: 10.1146/annurev-anchem-091411-121050. Epub 2012 Apr 9.

PMID:
22524227
43.

Occult breast cancer presenting as metastatic adenocarcinoma of unknown primary: clinical presentation, immunohistochemistry, and molecular analysis.

Wang J, Talmon G, Hankins JH, Enke C.

Case Rep Oncol. 2012 Jan;5(1):9-16. doi: 10.1159/000335449. Epub 2012 Jan 7.

44.

Prostate intrafraction translation margins for real-time monitoring and correction strategies.

Litzenberg DW, Balter JM, Hadley SW, Hamstra DA, Willoughby TR, Kupelian PA, Djemil T, Mahadevan A, Jani S, Weinstein G, Solberg T, Enke C, Levine L, Sandler HM.

Prostate Cancer. 2012;2012:130579. doi: 10.1155/2012/130579. Epub 2011 Jul 13.

45.

Resolution and mass range performance in distance-of-flight mass spectrometry with a multichannel focal-plane camera detector.

Graham AW, Ray SJ, Enke CG, Felton JA, Carado AJ, Barinaga CJ, Koppenaal DW, Hieftje GM.

Anal Chem. 2011 Nov 15;83(22):8552-9. doi: 10.1021/ac201876y. Epub 2011 Oct 24.

PMID:
21972781
46.

Analytical Chemistry, a great success despite the unfortunate divisions in academic departments.

Enke CG.

Talanta. 2011 Oct 15;85(5):2247-8. doi: 10.1016/j.talanta.2011.07.074. Epub 2011 Jul 27. No abstract available.

PMID:
21962640
47.

Sarcomatoid Urothelial Carcinoma: A Single Cancer Center Experience.

Wang J, Gillaspie C, Kunadharaju R, Talmon GA, Enke C.

World J Oncol. 2011 Aug;2(4):175-180. doi: 10.4021/wjon370w. Epub 2011 Aug 24.

48.

First distance-of-flight instrument: opening a new paradigm in mass spectrometry.

Graham AW, Ray SJ, Enke CG, Barinaga CJ, Koppenaal DW, Hieftje GM.

J Am Soc Mass Spectrom. 2011 Jan;22(1):110-7. doi: 10.1007/s13361-010-0005-8. Epub 2011 Jan 20.

PMID:
21472549
49.

Effect of radiotherapy techniques (IMRT vs. 3D-CRT) on outcome in patients with intermediate-risk rhabdomyosarcoma enrolled in COG D9803--a report from the Children's Oncology Group.

Lin C, Donaldson SS, Meza JL, Anderson JR, Lyden ER, Brown CK, Morano K, Laurie F, Arndt CA, Enke CA, Breneman JC.

Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1764-70. doi: 10.1016/j.ijrobp.2011.01.036. Epub 2011 Apr 4.

50.

Undetected components in natural mixtures: how many? What concentrations? Do they account for chemical noise? What is needed to detect them?

Enke CG, Nagels LJ.

Anal Chem. 2011 Apr 1;83(7):2539-46. doi: 10.1021/ac102818a. Epub 2011 Mar 2.

PMID:
21366323

Supplemental Content

Support Center